Invention Grant
- Patent Title: Porcine circovirus type-2 (PCV2) subunit vaccine
-
Application No.: US14363341Application Date: 2012-12-05
-
Publication No.: US09657063B2Publication Date: 2017-05-23
- Inventor: Tsun-Yung Kuo , Hsu-Chung Gabriel Chen , Shu-Hsiang Yang , Yu-San Chen
- Applicant: SBC VIRBAC BIOTECH CO., LTD.
- Applicant Address: HK Causeway Bay
- Assignee: SBC VIRBAC LIMITED
- Current Assignee: SBC VIRBAC LIMITED
- Current Assignee Address: HK Causeway Bay
- Agency: Locke Lord LLP
- Agent Tim Tingkang Xia, Esq.
- International Application: PCT/CN2012/085907 WO 20121205
- International Announcement: WO2013/083036 WO 20130613
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61K39/12 ; C07K14/21 ; C12N7/00 ; C07K5/103 ; A61K39/00

Abstract:
A porcine circovirus type-2 (PCV2) immunogenic composition includes an antigenic peptide. The antigenic peptide is a non-arginine-rich peptide of a PCV2 open reading frame 2 (ORF2) and/or a recombinant fusion protein having the non-arginine-rich peptide of the PCV2 ORF2, a PE peptide, and a KDEL signal peptide. The number of arginines of the non-arginine-rich peptide of the PCV2 ORF2 is not greater than half of the number of arginines of the arginine-rich domain of the N terminal of the PCV2 ORF2.
Public/Granted literature
- US20140348864A1 PORCINE CIRCOVIRUS TYPE-2 (PCV2) SUBUNIT VACCINE Public/Granted day:2014-11-27
Information query